Leramistat (HMC-C-01-A, MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation. Leramistat also inhibits ATP production in Thp1 human monocytes (IC50: 0.63 µM). Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer, and also inhibits osteoclast mediated disease[1][2][3].
Molekulargewicht:
404.91
Reinheit:
98.00
CAS Nummer:
[1642602-54-7]
Formel:
C20H21ClN2O3S
Target-Kategorie:
Mitochondrial Metabolism
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten